ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
Dow Jones
39.069,59
0,01%
Euro vs US Dollar
1,08507
0,03%
Bitcoin
69.053,55
0,79%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Daxor Corporation (DXR)

  7. Daxor Corporation (DXR) News

DXR

Daxor (DXR)

Daxor Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:DXR
DatumZeitQuelleÜberschriftSymbolFirma
16/04/202414h00GlobeNewswire Inc.New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of CongestionNASDAQ:DXRDaxor Corporation
15/04/202414h00GlobeNewswire Inc.DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™)NASDAQ:DXRDaxor Corporation
10/04/202414h00GlobeNewswire Inc.Daxor Corporation Announces New Hospital Account at Leading Chicago HospitalNASDAQ:DXRDaxor Corporation
01/04/202414h00GlobeNewswire Inc.Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24NASDAQ:DXRDaxor Corporation
25/03/202413h00GlobeNewswire Inc.Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of DiagnosticsNASDAQ:DXRDaxor Corporation
22/03/202413h00GlobeNewswire Inc.Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024NASDAQ:DXRDaxor Corporation
18/03/202419h18GlobeNewswire Inc.Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023NASDAQ:DXRDaxor Corporation
18/03/202419h18GlobeNewswire Inc.Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to ShareholdersNASDAQ:DXRDaxor Corporation
11/03/202413h00GlobeNewswire Inc.Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User BaseNASDAQ:DXRDaxor Corporation
08/03/202419h49Edgar (US Regulatory)Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report): [Amend]NASDAQ:DXRDaxor Corporation
08/03/202414h00GlobeNewswire Inc.Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure PatientsNASDAQ:DXRDaxor Corporation
06/03/202422h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
29/02/202423h28Edgar (US Regulatory)Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report): [Amend]NASDAQ:DXRDaxor Corporation
29/02/202422h15Edgar (US Regulatory)Form NT-NCSR - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report)NASDAQ:DXRDaxor Corporation
26/02/202414h00GlobeNewswire Inc.Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics ConferenceNASDAQ:DXRDaxor Corporation
12/02/202414h00GlobeNewswire Inc.Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer AcquisitionsNASDAQ:DXRDaxor Corporation
07/02/202414h00GlobeNewswire Inc.Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing AccountsNASDAQ:DXRDaxor Corporation
29/01/202414h00GlobeNewswire Inc.Daxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual MeetingNASDAQ:DXRDaxor Corporation
16/01/202414h00GlobeNewswire Inc.Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care CongressNASDAQ:DXRDaxor Corporation
09/01/202414h00GlobeNewswire Inc.DAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMESNASDAQ:DXRDaxor Corporation
02/01/202414h52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DXRDaxor Corporation
02/01/202414h30GlobeNewswire Inc.Daxor Corporation Submits Dual 510(k)/CLIA-waiver Application to the FDA for Its Advanced Next-Generation Blood Volume AnalyzerNASDAQ:DXRDaxor Corporation
06/12/202321h48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
02/12/202303h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
02/12/202303h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
02/12/202302h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
02/12/202302h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
27/11/202312h03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
24/11/202319h53Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)NASDAQ:DXRDaxor Corporation
24/11/202317h32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DXRDaxor Corporation
 Showing the most relevant articles for your search:NASDAQ:DXR

Kürzlich von Ihnen besucht

TG
RHM
Rheinmetall
TG
DBK
Deutsche Bank
CCOM
US500
US 500
USOTC
BASFY
BASF (QX)
NASDAQ
AAPL
Apple
NASDAQ
NVDA
NVIDIA
AMEX
XLF
Financial Select Sector
TG
CBK
Commerzbank
TG
D7G
Nel ASA
DBI
MDAX
MDAX
CCOM
SILVER
SILVER
USOTC
ADDYY
Adidas (QX)
AMEX
XLE
Energy Select Sector SPDR
USOTC
RHHBY
Roche (QX)
NYSE
DIS
Walt Disney
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten